Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock
IRVINE, Calif., March 03, 2023 (GLOBE NEWSWIRE) — Biomerica, Inc. (NASDAQ:BMRA) (“Biomerica”), a global provider of advanced medical products, announced today the pricing of its previously announced underwritten public offering. Biomerica is offering an aggregate of 3,333,333 shares of its common stock, par value $0.08 per share, at a price to the public of $2.40 per share. All shares of common stock in the offering are being offered by Biomerica.
Related news for (BMRA)
- United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use
- MoBot alert highlights: NASDAQ: BTBD, NYSE: NBY, NASDAQ: BMRA, NASDAQ: LCFY, NASDAQ: AIHS (09/03/25 08:00 AM)
- 24/7 Market News Snapshot 03 September, 2025 – BIOMERICA INC (NASDAQ:BMRA)
- United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Home Use
- MoBot’s Stock Market Highlights – 08/14/25 08:00 AM